Maxim Group Initiates Coverage On Acrivon Therapeutics with Buy Rating, Announces Price Target of $24

With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today…

Caleres Inc (NYSE:CAL) put forward its three-year strategic and financial plan in conjunction with its Oct. 5 Investor Day. The…

Investors seeking a combination of both growth and income from their portfolio have a number of compelling investment categories to…